Skip to content Skip to footer
Adalimumab-Adaz: Benefits, Reviews, Info, Side Effects!
Rx Details
Adalimumab-Adaz
Adalimumab, Adaz
Adalimumab
Prescription
Biologic
Drugs
Prescription Only
Adalimumab-Adaz is a biosimilar to adalimumab, which is used to treat various inflammatory conditions. Here are the benefits in a comma-separated list: reduces inflammation, alleviates symptoms of rheumatoid arthritis, treats psoriatic arthritis, manages ankylosing spondylitis, improves symptoms of Crohn’s disease, treats ulcerative colitis, reduces symptoms of plaque psoriasis, manages hidradenitis suppurativa, treats uveitis.
Abdominal Pain, Allergic Reactions, Back Pain, Cough, Cytopenias, Demyelinating Disease, Dizziness, Fatigue, Flu-Like Symptoms, Headache, Heart Failure, Hypertension, Increased Liver Enzymes, Injection Site Reactions, Lupus-Like Syndrome, Malignancies, Nausea, Rash, Serious Infections, Sinusitis, Upper Respiratory Infections, Urinary Tract Infections
Adalimumab-Adaz is a biosimilar to the reference biologic drug adalimumab, which is commonly used to treat various inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis, among others. The dosage of adalimumab, including its biosimilars like Adalimumab-Adaz, can vary depending on the specific condition being treated, the severity of the condition, and the patient’s response to the medication. For many conditions, the typical starting dose of adalimumab is an initial loading dose followed by a maintenance dose. For example, in rheumatoid arthritis, the usual dose is an initial 160 mg followed by 80 mg two weeks later, and then 40 mg every other week. However, dosing regimens can differ, so it is crucial to follow the specific guidance provided by a healthcare professional. It’s important to consult with a healthcare provider for the appropriate dosage tailored to the individual’s medical condition and needs.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, uveitis
Adalimumab-Adaz has a favorable safety profile.
No Interactions Reported
$1,000 – $2,000
$1,363.99

A Synopsis of

Adalimumab-Adaz

Adalimumab-Adaz is a medication that falls under the category of biologic drugs, specifically a tumor necrosis factor (TNF) blocker. It is used to treat a variety of inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.

This medication works by targeting and blocking TNF, a protein in the body that plays a key role in causing inflammation. By inhibiting TNF, Adalimumab-Adaz helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is important to note that Adalimumab-Adaz is typically prescribed for patients who have not responded well to other treatments or who have severe symptoms that significantly impact their quality of life. As with any medication, there are potential side effects to be aware of, including injection site reactions, infections, and an increased risk of certain types of cancer.

Before starting Adalimumab-Adaz, it is crucial to discuss your medical history and any other medications you are taking with your healthcare provider. They will be able to determine if this medication is the right choice for you and monitor your progress while on treatment.

Overall, Adalimumab-Adaz can be a valuable tool in managing chronic inflammatory conditions and improving quality of life for many patients. If you have any questions or concerns about this medication, do not hesitate to reach out to your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN